Princess Margaret Hospital and University of Toronto, Canada
Published: 28 Nov 2008
Views: 14742
Prof. Ian Tannock
Blood pressure and efficacy in patients with metastatic renal cell carcinoma receiving axitinib, from ESMO 2008
- Categories:
- Prostate & urology
Related Videos
Clinical genomic testing in prostate cancer
Laurie M Connors - Vanderbilt University School of Nursing, Nashville, USA
24 Nov 2020
PARP inhibitors for prostate cancer
Laurie M Connors - Vanderbilt University School of Nursing, Nashville, USA
24 Nov 2020
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
4 Nov 2020
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more...
Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA
4 Nov 2020
Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1 ba...
Dr Julius Strauss - National Institutes of Health, Bethseda, USA
4 Nov 2020
Extreme hypofractionation with stereotactic body radiation therapy for elderly p...
Dr Monica A Pernia - George Washington University, Washington DC, USA
30 Oct 2020
Updates in geriatric medical oncology from SIOG meeting
Dr Enrique Soto - Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zu...
28 Oct 2020
Synchronous invasive ductal carcinoma of the breast and clear cell renal carcino...
Dr Mona Hassan - American University of Beirut Medical Center, Beirut, Lebanon
8 Oct 2020
PROFound trial and other recent updates in prostate cancer
Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
25 Sep 2020
